These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17970028)

  • 1. Cancer-targeting gene therapy using tropism-modified adenovirus.
    Tanaka T; Kuroki M; Hamada H; Kato K; Kinugasa T; Shibaguchi H; Zhao J; Kuroki M
    Anticancer Res; 2007; 27(6A):3679-84. PubMed ID: 17970028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.
    Krasnykh V; Dmitriev I; Navarro JG; Belousova N; Kashentseva E; Xiang J; Douglas JT; Curiel DT
    Cancer Res; 2000 Dec; 60(24):6784-7. PubMed ID: 11156365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.
    Fechner H; Haack A; Wang H; Wang X; Eizema K; Pauschinger M; Schoemaker R; Veghel R; Houtsmuller A; Schultheiss HP; Lamers J; Poller W
    Gene Ther; 1999 Sep; 6(9):1520-35. PubMed ID: 10490761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
    Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
    Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
    Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer.
    Van Geer MA; Brevoord D; Kuhlmann KF; Bakker CT; Mizuguchi H; Wesseling JG; Ten Kate FJ; Gouma DJ; Oude Elferink RP; Bosma PJ
    Int J Oncol; 2010 Jan; 36(1):233-44. PubMed ID: 19956852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vector retargeting for cancer gene therapy.
    Wei W; Xue JL; Tian L
    Ai Zheng; 2009 Jan; 28(1):86-90. PubMed ID: 19448427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.
    Nicklin SA; Von Seggern DJ; Work LM; Pek DC; Dominiczak AF; Nemerow GR; Baker AH
    Mol Ther; 2001 Dec; 4(6):534-42. PubMed ID: 11735337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta.
    Brüning A; Runnebaum IB
    Gene Ther; 2003 Feb; 10(3):198-205. PubMed ID: 12571626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral vectors for gene transfer and therapy.
    Volpers C; Kochanek S
    J Gene Med; 2004 Feb; 6 Suppl 1():S164-71. PubMed ID: 14978759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus receptors: implications for tropism, treatment and targeting.
    Arnberg N
    Rev Med Virol; 2009 May; 19(3):165-78. PubMed ID: 19367611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.
    Kanerva A; Wang M; Bauerschmitz GJ; Lam JT; Desmond RA; Bhoola SM; Barnes MN; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
    Mol Ther; 2002 Jun; 5(6):695-704. PubMed ID: 12027553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral vectors: systemic delivery and tumor targeting.
    Green NK; Seymour LW
    Cancer Gene Ther; 2002 Dec; 9(12):1036-42. PubMed ID: 12522442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of PEGylated adenovirus vector with targeting ligand.
    Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
    Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.
    Haviv YS; Blackwell JL; Kanerva A; Nagi P; Krasnykh V; Dmitriev I; Wang M; Naito S; Lei X; Hemminki A; Carey D; Curiel DT
    Cancer Res; 2002 Aug; 62(15):4273-81. PubMed ID: 12154029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
    Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
    Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
    Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.
    Renaut L; Colin M; Leite JP; Benko M; D'Halluin JC
    Virology; 2004 Apr; 321(2):189-204. PubMed ID: 15051380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral strategies for the gene therapy of cancer.
    Relph KL; Harrington KJ; Pandha H
    Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.